Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pedigree Analysis

Pedigree Analysis

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Incomplete Dominance

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.

Probability Laws

Probability Laws

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial.

BMC geriatrics·2025

Same author

Pilot study MOVENDOP protocol - impact on quality of life following postoperative osteopathic abdominal mobilizations in patients operated for endometriosis.

PloS one·2025

Same author

Statistical algorithms for the analysis of deleterious genetic mutations.

Bio Systems·2025

Same author

Benefits of using corneal topography to choose subjective refraction technique in keratoconus (RE-CON): a prospective comparative crossover clinical study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2021

Same author

Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer.

Cancer medicine·2021

Same author

Continuous Wound Infiltration With Ropivacaine After Mastectomy: A Randomized Controlled Trial.

The Journal of surgical research·2020

Search research articles

Related Experiment Video

Updated: Aug 11, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Oncogenetic pedigrees: Relation between design and ability to predict mutation.

Fabrice Kwiatkowski¹, Laurent Serlet¹, Andrzej Stos¹

¹Université Clermont Auvergne, CNRS, Laboratoire de Mathématiques Blaise Pascal (UMR 6620), F-63000, Clermont-Ferrand, France.

|February 6, 2023

Summary

This summary is machine-generated.

This study estimates disease risk from single or interacting gene mutations using family history. Simulations with breast/ovarian cancer data in BRCA families show how family structure impacts risk prediction accuracy.

Keywords:

Family pedigree Oncogenetics Risk modelization Simulation

More Related Videos

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Related Experiment Videos

Last Updated: Aug 11, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Area of Science:

Genetics
Computational Biology
Epidemiology

Background:

Genetic mutations, single or interacting, are key drivers of inherited diseases.
Family history and pedigree analysis are crucial for assessing genetic disease risk.
Understanding mutation interactions and family structure is vital for accurate risk prediction.

Purpose of the Study:

To evaluate the accuracy of estimating individual mutation status (single or double) using family pedigree data.
To analyze how family tree size and shape influence the performance of genetic risk prediction models.
To apply and validate the model using parameters from BRCA-mutated families with breast and ovarian cancer.

Main Methods:

Development of a probabilistic model to estimate mutation and double mutation probabilities within a family.
Simulation studies to assess model performance across various family pedigree structures and genetic parameters.
Application of the model using real-world data from breast/ovarian cancer families with BRCA mutations.

Main Results:

The study demonstrates that family pedigree information can effectively estimate an individual's probability of carrying disease-causing mutations.
Model performance is sensitive to family tree size and shape, indicating structural factors influence risk prediction accuracy.
Simulations using BRCA-related cancer data provide insights into the practical application of the developed risk assessment method.

Conclusions:

The developed model offers a robust framework for assessing genetic disease risk based on family history and mutation interactions.
Family structure plays a significant role in the precision of genetic risk prediction, highlighting the need for tailored analyses.
This approach has implications for genetic counseling and personalized medicine, particularly for hereditary cancers like those linked to BRCA mutations.